MF Researcher Database

Researchers Database

Advance

Position： Professor
Last Updated :2025/04/28

Profiles

Affiliation

  • Professor

Profile and Settings

Affiliation

  • Dokkyo Medical University, Department of Genomic Diagnosis and Laboratory Medicine, Professor and Chair, Prof lv, Director, Clinical Laboratory

Degree

  • Mar. 1997

Research Experience

  • 01 Apr. 2017, Japan

Committee Memberships

  • 01 Apr. 2022
  • 01 Apr. 2022
  • 01 Apr. 2022
  • 01 Apr. 2024
  • 01 Apr. 2022
  • 01 Apr. 2022
  • 01 Apr. 2023
  • 01 Apr. 2024
  • 01 Apr. 2022
  • 01 Apr. 2024
  • 01 Apr. 2022
  • 01 Apr. 2022
  • 01 Oct. 2023
  • Society
  • Society

Association Memberships

  • 2006, American Thyroid Association, Active Member
  • 2000, The Endocrine Society, Active Member
  • 日本臨床化学会
  • 日本医療検査科学会
  • アメリカ甲状腺学会
  • アメリカ内分泌学会
  • 日本人類遺伝学会
  • 日本甲状腺学会
  • 日本内分泌学会
  • 日本臨床微生物学会
  • 日本臨床検査医学会

Research achievements

Awards

  • 2002, American Thyroid Association, Poster Prize, Systemic retinoic acid treatment induces radioiodide uptake and sodium/iodide symporter mRNA expression in mouse breast cancer models., Kogai T, Kanamoto Y, Taki K, Schultz JJ, Brent GA
  • 2001, The American Society for Clinical Investigation/Association of American Physicians, Travel Grant, Retinoic acid induces radioiodide uptake and sodium/iodide symporter mRNA expression in mouse breast cancer models., Kogai T, Schultz JJ, Kanamoto K, Taki K, Johnson LS, Brent GA
  • 2022, Official journal

Published Papers

    Original paper
  • Inhibition of IL-33 signaling ameliorate hepatic fibrosis with decreasing MCP-1 in a mouse model of diabetes and non-alcoholic steatohepatitis; comparison for luseogliflozin, an SGLT2 inhibitor., 38, 1(108650), 23 Nov. 2023
    Permalink
  • Empagliflozin increases plasma levels of campesterol, a marker of cholesterol absorption, in patients with type 2 diabetes: Association with a slight increase in high-density lipoprotein cholesterol., 331, (243), 248, 15 May 2021
  • A Japanese Family with DICER1 Syndrome Found in Childhood-Onset Multinodular Goitre., 93, 7-8(477), 482-true, 20 Oct. 2020
  • The SGLT2 Inhibitor Canagliflozin Prevents Carcinogenesis in a Mouse Model of Diabetes and Non-Alcoholic Steatohepatitis-Related Hepatocarcinogenesis: Association with SGLT2 Expression in Hepatocellular Carcinoma., 20, 20, 22 Oct. 2019
  • 51, 5(500), Oct. 2023
    Permalink
  • 34, 1(271), Sep. 2023
    Permalink
  • 48, 4(377), Aug. 2023
    Permalink
  • 48, 4(416), Aug. 2023
    Permalink
  • 17, 1(15-25), Mar. 2023
    Permalink
  • 49, 2(123), Dec. 2022
    Permalink
  • 16, 2(16-22), Mar. 2022
  • 16, 2(49-58), Mar. 2022
  • 16, 2(59-67), Mar. 2022
  • 48, 2(116), Jul. 2021
    DOI
  • Genetic alteration of ARMC5 in a patient diagnosed with meningioma and primary macronodular adrenal hyperplasia: a case report., 183, 6(K7), K12-true, Dec. 2020
    Permalink
  • 15, 2(15), 20-false, Mar. 2020
  • 15, 2(47), 54-false, Mar. 2020
  • 75, 11(1453-1460), Oct. 2018
    DOI
  • 別冊, 内分泌症候群I(372), 376-false, Sep. 2018
  • 別冊, 内分泌症候群I(381), 384-false, Sep. 2018
  • 別冊, 内分泌症候群I(377), 380-false, Sep. 2018
  • 75, 8(935-943), Jul. 2018
    DOI
  • 75, 7(833), 840, Jun. 2018
  • A Novel Germline Mutation of KEAP1 (R483H) Associated with a Non-Toxic Multinodular Goiter, 7, (131), -true, Sep. 2016
  • Iodide Transport Defect and Breast Milk Iodine, 5, 2(145), 148, Jul. 2016
  • Graves' disease and Gitelman syndrome, 84, 1(149), 150-false, Jan. 2016
  • 1, 2(139), 141-false, Aug. 2015
  • Thyroid hormone receptor isoform-specific modification by small ubiquitin-like modifier (SUMO) modulates thyroid hormone-dependent gene regulation, 287, 43(36499), 36508-true, Oct. 2012
  • Regulation of sodium iodide symporter gene expression by Rac1/p38beta mitogen-activated protein kinase signaling pathway in MCF-7 breast cancer cells, 287, 5(3292), 3300-true, Jan. 2012
  • Thyroid hormone and COUP-TF1 regulate kallikrein-binding protein (KBP) gene expression, 152, 3(1143), 1153-true, Mar. 2011
  • Retinoic acid induces expression of the thyroid hormone transporter, monocarboxylate transporter 8 (Mct8), 285, 35(27279), 27288-true, Aug. 2010
  • Activation of the PI3 kinase pathway by retinoic acid mediates sodium/iodide symporter induction and iodide transport in MCF-7 breast cancer cells, 69, 8(3443), 3450-true, Apr. 2009
  • Phosphoinositide-3-kinase inhibition induces sodium/iodide symporter expression in rat thyroid cells and human papillary thyroid cancer cells, 199, 2(243), 252-true, Nov. 2008
  • Retinoic acid stimulation of the sodium/iodide symporter in MCF-7 breast cancer cells is mediated by the insulin growth factor-I/phosphatidylinositol 3-kinase and p38 mitogen-activated protein kinase signaling pathways, 93, 5(1884), 1892-true, May 2008
  • PTTG and PBF repress the human sodium iodide symporter, 26, 30(4344), 4356-true, Jun. 2007
  • Differential regulation of sodium/iodide symporter gene expression by nuclear receptor ligands in MCF-7 breast cancer cells, 146, 7(3059), 3069-true, Jul. 2005
  • Systemic retinoic acid treatment induces sodium/iodide symporter expression and radioiodide uptake in mouse breast cancer models, 64, 1(415), 422-true, Jan. 2004
  • Nonradioactive iodide effectively induces apoptosis in genetically modified lung cancer cells, 63, 16(5065), 5072-true, Aug. 2003
  • A GC box in the human sodium iodide symporter gene promoter is essential for full activity, 12, 2(107), 114-true, Feb. 2002
  • Ectopic expression of the thyroperoxidase gene augments radioiodide uptake and retention mediated by the sodium iodide symporter in non-small cell lung cancer, 8, 8(612), 618-true, Aug. 2001
  • Retinoic acid induces sodium/iodide symporter gene expression and radioiodide uptake in the MCF-7 breast cancer cell line, 97, 15(8519), 8524-true, Jul. 2000
  • Transforming growth factor-beta1 suppresses thyrotropin-induced Na+/I- symporter messenger RNA and protein levels in FRTL-5 rat thyroid cells, 7, 5(789), 794-true, Oct. 1997
  • Autoantibody against thyroid iodide transporter in the sera from patients with Hashimoto's thyroiditis possesses iodide transport inhibitory activity, 228, 1(199), 202-true, Nov. 1996
  • Autoantibody against Na+/I- symporter in the sera of patients with autoimmune thyroid disease, 224, 1(92), 95-true, Jul. 1996
  • Structure of the rat thyroid transcription factor-1 (TTF-1) gene, 204, 3(1358), 1363-true, Nov. 1994
  • A novel role for Niemann-Pick disease type 2C protein in papillae formation, 6, 1(e15777), -true, 2011
  • Functional variants in a TTTG microsatellite on 15q26.1 cause familial nonautoimmune thyroid abnormalities., Narumi Satoshi;Nagasaki Keisuke;Kiriya Mitsuo;Uehara Erika;Akiba Kazuhisa;Tanase-Nakao Kanako;Shimura Kazuhiro;Abe Kiyomi;Sugisawa Chiho;Ishii Tomohiro;Miyako Kenichi;Hasegawa Yukihiro;Maruo Yoshihiro;Muroya Koji;Watanabe Natsuko;Nishihara Eijun;Ito Yuka;Kogai Takahiko;Kameyama Kaori;Nakabayashi Kazuhiko;Hata Kenichiro;Fukami Maki;Shima Hirohito;Kikuchi Atsuo;Takayama Jun;Tamiya Gen;Hasegawa Tomonobu, Nature genetics, 56(5), 869-876, 07 May 2024
    DOI
  • Diabetes with GLP-1R polymorphism (rs3765467) accompanied by myotonic dystrophy: A case of myotonic dystrophy with p.R131Q polymorphism at the glucagon-like peptide-1 receptor (rs3765467) resulting in marked effects of its agonist, dulaglutide., Kato Kanako;Jojima Teruo;Kogai Takahiko;Tanuma Dai;Niitani Takafumi;Sakurai Shintaro;Iijima Toshie;Tomaru Takuya;Usui Isao;Aso Yoshimasa, The American journal of the medical sciences, 08 Jul. 2024
    DOI
    Review paper
  • 1, 49, 9(938), 943-false, 01 Sep. 2021
    DOI
  • 111, 5(589-593), May 2023
    Permalink
  • 65, 2(31), Mar. 2023
    Permalink
  • 8回, (87), Jun. 2022
    Permalink
  • 68, 2(41-46), Feb. 2022
    DOI
  • 53, 5(467-472), Nov. 2021
  • 38, 4(37-41), Oct. 2021
  • 48, 3(243-253), Oct. 2021
    DOI
  • 49, 9(938-943), Sep. 2021
  • The sodium iodide symporter (NIS): regulation and approaches to targeting for cancer therapeutics, 135, 3(355), 370-true, Sep. 2012
  • Enhancement of sodium/iodide symporter expression in thyroid and breast cancer, 13, 3(797), 826-true, Sep. 2006
    Case report
  • A CASE OF FAMILIAL NONAUTOIMMUNE HYPERTHYROIDISM DURING PREGNANCY., 6, 2(e94), e97-true, 22 Jan. 2020
  • Congenital Primary Hypothyroidism with the Homozygous Nonsense Mutation P.K1374* in the Thyroglobulin Gene and a Normal-sized Thyroid Gland on Levothyroxine Replacement., 58, 18(2669), 2673, 15 Sep. 2019
  • Denosumab improves clinical manifestations of hypophosphatemic osteomalacia by adefovir-induced Fanconi syndrome: a case report., 13, 1, 20 Apr. 2019
  • 72, 6-7(938), Aug. 2023
    Permalink
  • 99, 1(301), May 2023
    Permalink
  • 99, 1(301), May 2023
    Permalink
  • 36, 1(116), Apr. 2023
    Permalink
  • 98, 5(1309), Mar. 2023
    Permalink
  • 17, 1(5-10), Mar. 2023
    Permalink
  • 33, Suppl.1(255), Dec. 2022
  • 58回, (119), Oct. 2022
  • 98, 1(311), Apr. 2022
  • 97, 5(1145), Mar. 2022
  • 97, 4(800), Dec. 2021
  • 671回, (37), Sep. 2021
  • 97, 1(278), Apr. 2021
    DOI
  • 96, 4(977), Apr. 2021
    DOI
  • A case of hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome with a novel frameshift variant in GATA3, p.W10Cfs40, lacks kidney malformation., 8, 12(2619), 2624-true, Dec. 2020
  • 96, 1(347), Aug. 2020
  • 15, 2(55), 61-false, Mar. 2020
  • 95, 4(1333), Feb. 2020
  • 95, 4(1368), Feb. 2020
  • 25, Suppl., Oct. 2019
  • 95, 2(731), Oct. 2019
  • 95, 2(789), Oct. 2019
  • 95, 1(351), Apr. 2019
  • 62, Suppl.1(S), 250, Apr. 2019
    Permalink
  • 95, 1(395), Apr. 2019
  • 95, 1(493), Apr. 2019
  • 94, 4(1229), Dec. 2018
  • 94, 4(1256), Dec. 2018
  • 55回, Oct. 2018
  • 94, 2(689), Sep. 2018
  • 94, 2(692), Sep. 2018
  • 94, SupplUpdate(20), 22, Jun. 2018
  • 94, 1(357), Apr. 2018
  • 94, 1(398), Apr. 2018
  • 93, 3(762), Dec. 2017
  • 93, 4(1126), Dec. 2017
  • PTEN mutation in a Japanese boy with autonomously functioning thyroid nodule, 59, 11(1223), 1224-true, Nov. 2017
  • 93, 2(539), Oct. 2017
  • 93, 2(562), Oct. 2017
  • 93, 1(323), Apr. 2017
  • 92, 2(475), Oct. 2016
  • 92, 1, Apr. 2016
  • 92, 1(238), Apr. 2016
  • 92, 1(269), Apr. 2016
  • 26, Suppl.(355), Dec. 2015
  • 91, 2Suppl.(92), Nov. 2015
  • 91, 2Suppl.(109), Nov. 2015
  • 119, 8(1313), Aug. 2015
  • 119, 2(432), Feb. 2015
  • 90, 2(542), Sep. 2014
  • 90, 2(543), Sep. 2014
  • 63, 学会特集号(301), Apr. 2014
  • 90, 1(341), Apr. 2014
  • 90, 1(369), Apr. 2014
  • 89, 3(991), Dec. 2013
  • 89, 3(977), Dec. 2013
  • 4, 2(126), 128-false, Oct. 2013
  • 89, 2(462), Sep. 2013
    Permalink
  • A case of Pendred's syndrome with hyperparathyroidism., 43, (151), 154-false, Jan. 1995
  • 69, 8(784), Sep. 1993
    Other
  • Munekazu YMAKUCHI,MD,PhD and Takahiko KOGAI,MD,Phd, 第71巻(第3号), 170-171, 25 Mar. 2023
  • Sodium iodide symporter in the fight against thyroid cancer., 9, 11(1679), 1682-true, Nov. 2013
  • Cancer: Novel target to enhance radioiodine uptake in thyroid cancer., 9, 9(508), 509-true, Sep. 2013
    Unclear
  • Nodule-specific NRF2-targeted upregulation in patients with KEAP1 mutations and familial nontoxic multinodular goiter., Nishihara Eijun;Fukata Shuji;Hirokawa Mitsuyoshi;Higuchi Miyoko;Ito Mitsuru;Nishikawa Mitsushige;Miyauchi Akira;Matsuse Michiko;Mitsutake Norisato;Ito Yuka;Hishinuma Akira;Kogai Takahiko;Akamizu Takashi, The Journal of clinical endocrinology and metabolism, 07 Oct. 2024
    DOI

Books etc

  • Comprehensive Handbook on Iodine, 1st Edition, Regulation and Enhancement of the Sodium Iodide Symporter Expression: NIS Regulatory Pathways in Thyroid and Breast Cancer., Joint work, Victor R. Preedy, Gerard N. Burrow, Ronald R. Watson, Elsevier (Academic Press), Feb. 2009, 221-230, 9780123741356
  • Endocrinology-Basic and Clinical Principles, 2nd Edition, Thyroid Hormones (T4, T3), Joint work, Shlomo Melmed, P. Michael Conn, Humana Press, Jun. 2005, 267-281, 1588294277
  • Contributor, 30 Sep. 2019, 326, 315-319, Not refereed, Japanese, Scholarly book
  • Joint work, 30 Sep. 2019, 326, 23-24, Not refereed, Japanese, Scholarly book
  • Contributor, 30 Sep. 2019, 326, 11-14, Not refereed, Japanese
  • Contributor, Mar. 2021, Japanese
  • Contributor, Mar. 2021, Japanese
  • Contributor, Mar. 2021, Japanese

Presentations

  • Activation of the human sodium/iodide symporter upstream enhancer cAMP response element-like sequence by PKA-dependent and PKA-independent pathways in normal thyroid and thyroid cancer cells, Taki K, Kogai T, Kanamoto Y, Hershman JM, Brent GA, 2002, Poster presentation, 74th Annual Meeting of the American Thyroid Association, True
  • Activation of the promoter of human sodium/iodide symporter gene by SP1 protein, Xu J, Kogai T, Brent GA, Hershman JM, 83rd Annual Meeting of the Endocrine Society, 2001, Poster presentation, 83rd Annual Meeting of the Endocrine Society, Denver, Colorado, True
  • Cloning and analysis of rat thyroid transcription factor-1 (TTF-1) gene, Ohno M, Nakazato M, Kogai T, Endo T, Onaya T, 11th International Thyroid Congress, 1995, Oral presentation, 11th International Thyroid Congress, True
  • Differential expression of the human sodium/iodide symporter gene promoter in papillary thyroid carcinoma cell lines and normal thyroid cells, Takahiko Kogai, 25 Mar. 2002, Invited oral presentation, Arena Pharmaceuticals, La Jolla, California, USA, True
  • Differential expression of the selenium binding protein-1 in thyroid cancer cell lines, Kogai T, Kanamoto Y, Caldwell J, Walker J, Hershman JM, Brent GA, 74th Annual Meeting of the American Thyroid Association, 2002, Poster presentation, 74th Annual Meeting of the American Thyroid Association, True
  • Differential regulation of the human sodium/iodide symporter gene promoter in normal thyroid, thyroid cancer, and breast cancer, Brent GA, Kogai T, Taki K, Hershman JM, The TSHR in Autoimmune Disease and Cancer, Mar. 2002, Public symposium, The TSHR in Autoimmune Disease and Cancer, Arena Pharmaceuticals, True
  • Effect of perchlorate on thyroid cell function and growth, Tran N, Kogai T, Blount BC, Gibbs C, Valentin-Blasini L, Hershman JM, The TSR&TP (Univ of California, Toxic Substances Research &Teaching Program) 19th Annual Research Symposium, 2006, Poster presentation, The TSR&TP (Univ of California, Toxic Substances Research &Teaching Program) 19th Annual Research Symposium, True
  • Enhancement of the Sodium/Iodide Symporter (NIS) Expression by PI3 Kinase Inhibitor in Thyroid Cancer Cells, Kogai T, Sajid-Crockett S, and Brent GA, 78th Annual Meeting of the American Thyroid Association, 2007, Poster presentation, 78th Annual Meeting of the American Thyroid Association, True
  • 2017 Asia Oceania Thyroid Association (AOTA) Congress, Mar. 2017, Poster presentation, True
  • Expression of the Na+/I- symporter is increased in thyrotropin-stimulated cultured human thyroid cells, Graves' thyroid tissues and autonomously functioning thyroid nodules, Saito T, Endo T, Kawaguchi A, Ikeda M, Nakazato M, Kogai T, Onaya T, 6th Asia & Oceania Thyroid Congress, 1997, Oral presentation, 6th Asia & Oceania Thyroid Congress, True
  • Expression of the sodium/iodide symporter in normal human thyroid cells, Hershman JM, Kogai T, Curcio F, Brent GA, The TSHR in Autoimmune Disease and Cancer, Mar. 2002, Public symposium, The TSHR in Autoimmune Disease and Cancer, Arena Pharmaceuticals, True
  • Germ-line variants of goiter-related genes in patients with familial nontoxic goiter, Kogai Takahiko;Hishinuma Akira, Feb. 2020, Oral presentation
  • Increased expression of the Na+/I- symporter in cultured human thyroid cells by thyrotropin and in Graves' thyroid tissues, Saito T, Endo T, Kawaguchi A, Ikeda M, Nakazato M, Kogai T, Onaya T, 24th Annual Meeting of the European Thyroid Association, 1997, Oral presentation, 24th Annual Meeting of the European Thyroid Association, True
  • Increased radioisotope uptake in non-small cell lung cancer following transfection with the sodium/iodide symporter gene, Huang M, Kogai T, Lin Y, Hershman JM, Brent GA, Dubinett SM, 8th International Conference on Gene Therapy of Cancer, 1999, Oral presentation, 8th International Conference on Gene Therapy of Cancer, True
  • Induction of follicle formation in primary human thyroid cells stimulates iodide uptake but not sodium/iodide symporter mRNA, Kogai T, Brent GA, Curcio F, Hershman JM, 81st Annual Meeting of the Endocrine Society, 1999, Poster presentation, 81st Annual Meeting of the Endocrine Society, True
  • Nuclear factor(s) are decreased in human papillary thyroid cancer cell line with reduced sodium/iodide symporter promoter expression, Kogai T, Hershman JM, Brent GA, 72nd Annual Meeting of the American Thyroid Association, 1999, Poster presentation, 72nd Annual Meeting of the American Thyroid Association, True
  • Annual Meeting of the American Thyroid Association, Oct. 2017, Poster presentation, True
  • Rabbit antibodies against N-terminal region of rat thyrotropin receptor possess thyroid-stimulation blocking activity, Kawaguchi A, Kogai T, Endo T, Onaya T, 69th Annual Meeting of the American Thyroid Association, 1996, Poster presentation, 69th Annual Meeting of the American Thyroid Association, True
  • Regulation of sodium/iodide symporter promoter expression in human papillary thyroid carcinoma cell lines and normal human thyroid cells, Kogai T, Brent GA, Curcio F, Endo T, Onaya T, Hershman JM, 71st Annual Meeting of the American Thyroid Association, 1998, Poster presentation, 71st Annual Meeting of the American Thyroid Association, True
  • Regulation of the sodium iodide symporter - its potential application to cancer therapy., Takahiko Kogai, Seoul International Congress of Endocrinology and Metabolism, 04 May 2013, Invited oral presentation, Seoul International Congress of Endocrinology and Metabolism, Grand Hilton Hotel, Seoul, Korea, True
  • Regulation of the sodium iodide symporter by retinoic acid in breast cancer, Richter LL, Kogai T, Brent GA, 2010 Western Regional Meeting, 2010, Oral presentation, 2010 Western Regional Meeting, American Federation for Medical Research, True
  • Repression of the human NIS upstream enhancer (hNUE) by PTTG, Smith VE, Boelaert K, Stratford AL, James SR, Susarla R, Kogai T, Eggo MC, Franklyn JA, McCabe CJ, 8th European Congress of Endocrinology, 2006, Poster presentation, 8th European Congress of Endocrinology, Glasgow, True
  • Repression of the human NIS upstream enhancer (hNUE) by PTTG and PBF, Smith VE, Boelaert K, Stratford AL, James SR, Susarla R, Kogai T, Eggo MC, Franklyn JA, McCabe CJ, 77th Annual Meeting of the American Thyroid Association, 2006, Poster presentation, 77th Annual Meeting of the American Thyroid Association, True
  • Retinoic acid (RA) regulates expression of the vitamin A transporter, STRA6, by different pathways in embryonic carcinoma (F9) and MCF7 breast cancer cell lines., Kirmiz S, Ohashi E, Mody K, Kogai T, Brent GA, 2009 Annual Meeting of the Endocrine Society, 2009, Poster presentation, ENDO 2009, Annual Meeting of the Endocrine Society, True
  • Retinoic acid induces expression of the thyroid hormone transporter Mct8 in mouse embryonic carcinoma cells, Mody K, Kogai T, Richter LL, Brent GA, 2010 Annual Meeting of the Endocrine Society, 2010, Poster presentation, ENDO 2010, Annual Meeting of the Endocrine Society, True
  • Retinoic acid induces radioiodide uptake and sodium/iodide symporter mRNA expression in mouse breast cancer models, Kogai T, Schultz JJ, Kanamoto K, Taki K, Johnson LS, Brent GA, The American Society for Clinical Investigation/Association of American Physicians-Joint Meeting 2001, 2001, Poster presentation, The American Society for Clinical Investigation/Association of American Physicians-Joint Meeting 2001, True
  • Retinoic acid induces sodium/iodide symporter gene expression in MCF7 breast cancer cells through activation of the PI3K/Akt pathway, Ohashi E, Kogai T, Brent GA, 97th Annual Meeting of the American Association for Cancer Research, 2006, Poster presentation, 97th Annual Meeting of the American Association for Cancer Research, True
  • Systemic retinoic acid treatment induces radioiodide uptake and sodium/iodide symporter mRNA expression in mouse breast cancer models, Kogai T, Kanamoto Y, Taki K, Schultz JJ, Brent GA, 74th Annual Meeting of the American Thyroid Association, 2002, Poster presentation, 74th Annual Meeting of the American Thyroid Association, True
  • Systemic retinoic acid treatment induces sodium/iodide symporter expression and radioiodide uptake in mouse breast cancer models, Kogai T, Kanamoto Y, Che LH, Taki K, Moatamed F, Schultz JJ, Brent GA, Somatostatin Receptor Physiology & Targets for Somatostatin Analogue Therapy-Young Investigators Meeting, 2003, Poster presentation, Somatostatin Receptor Physiology & Targets for Somatostatin Analogue Therapy-Young Investigators Meeting, True
  • The existence of thyrotropin receptor on clonal osteoblast-like osteosarcoma cells, Inoue M, Kogai T, Tawata M, 22nd Annual Meeting of the European Thyroid Association, 1994, Oral presentation, 22nd Annual Meeting of the European Thyroid Association, True
  • The sodium iodide symporter (NIS) is repressed by PTTG via the human NIS upstream enhancer (hNUE), Smith V, Boelaert k, Stratford A, James S, Kogai T, Franklyn J, and McCabe C, Society for Endocrinology BES 2007, 2007, Poster presentation, Society for Endocrinology BES 2007, True
  • The sodium iodide symporter (NIS) is repressed by PTTG via the human NIS upstream enhancer (hNUE), Smith VE, Boelaert K, Stratford AL, James SR, Susarla R, Kogai T, Eggo MC, Franklyn JA, McCabe CJ, 2006 Annual Meeting of the Endocrine Society, 2006, Poster presentation, ENDO 2006, Annual Meeting of the Endocrine Society, True
  • The sodium/iodide symporter in papilary thyroid carcinoma, Hershman JM, Kogai T, Brent GA, Thyroid One, Thyroid Cancer International Symposium, 1998, Public symposium, Thyroid One, Thyroid Cancer International Symposium, True
  • TSH stimulation of I- uptake by thyrocytes is due to an increase in Na+/I- symporter gene expression followed by its protein synthesis, Kogai T, Endo T, Saito T, Onaya T, 69th Annual Meeting of the American Thyroid Association, 1996, Others, 69th Annual Meeting of the American Thyroid Association, True

Educational activity

Teaching Experience

  • 01 Apr. 2013, 31 Mar. 2020, Clinical Endocrinology and Metabolism
  • 01 Apr. 2013, Clinical Laboratory Medicine
  • 2013, 2013, Clinical Laboratory Medicine
  • 2013, Basic Medical Science

教育活動上特質すべき事項

  • Jul. 2014
  • Apr. 2013
  • Apr. 2013
  • Jul. 2004, Dec. 2012

Social contributions

Social Contribution

  • Lecture, 24 Jan. 2015, 24 Jan. 2015
  • Lecture, 08 Feb. 2020, 08 Feb. 2020
  • Lecture, 17 Oct. 2020, 17 Oct. 2020
  • Seminar, 03 Jun. 2017, 03 Jun. 2017
  • 24 Jul. 2013, 24 Jul. 2013
  • 23 Jun. 2021, 23 Jun. 2021
  • Others, 2023
  • Others, 2022
  • Others, 2022
  • Others, 2022
  • Others, 2024

Academic Contribution

  • Academic society etc, Nov. 2018, Not contributing to international academic
  • May 2018, Not contributing to international academic
  • Nov. 2017, Not contributing to international academic
  • Oct. 2017, Oct. 2017, International academic contribution
  • Academic society etc, Apr. 2017, Not contributing to international academic
  • 01 Apr. 2016, 31 Mar. 2021, Not contributing to international academic
  • ad hoc reviewer of abstracts submitted for the Endocrine Society’s 97th Annual Meeting, Endocrine Society, Nov. 2014, Dec. 2014, International academic contribution
  • ad hoc reviewer of a proposal for research grant, National Science Center, Poland, Sep. 2014, Sep. 2014, International academic contribution
  • ad hoc reviewer of abstracts submitted for the Endocrine Society’s 96th Annual Meeting, Endocrine Society, Feb. 2014, Feb. 2014, International academic contribution
  • ad hoc reviewer of a proposal for research grant, The Hungarian Scientific Research Fund, Apr. 2013, Apr. 2013, International academic contribution
  • ad hoc reviewer of abstracts submitted for the Endocrine Society’s 95th Annual Meeting, Endocrine Society, Feb. 2013, Feb. 2013, International academic contribution
  • 01 Apr. 2022
  • 01 Apr. 2022
  • 01 Apr. 2022
  • 01 Apr. 2022
  • 01 Apr. 2022, 31 Mar. 2024
  • 01 Apr. 2022
  • 01 Apr. 2022
  • 01 Apr. 2022
  • Academic society etc, 01 Apr. 2016
  • Thyroid Science Editorial board member, Others, Thyroid Science Editorial board member, Oct. 2023
  • Academic society etc, 対応委員（corresponding member）, 01 Mar. 2024
  • Academic society etc, 01 Apr. 2023
  • Academic society etc, 01 Apr. 2022
  • Academic society etc, 01 Apr. 2022
  • Academic society etc, 01 Apr. 2024
  • Academic society etc, 01 Apr. 2023
  • Academic society etc, 01 Apr. 2024
  • Jul. 2024

University administration

学内委員会等活動

  • 2014
  • 2022
  • 2016
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022, 2023
  • 2022, 2023
  • 2022
  • 2023
  • 2024
  • 2024
  • 2024
  • 2024

Copyright © MEDIA FUSION Co.,Ltd. All rights reserved.